RxDoctor Payments DataLook up a doctor →

Sandra Johnson, MD

Dermatology · Fort Smith, ARNPI 1447256102

Payments from drug & device makers

$5,988,156in general payments, 2019–2025

Across 3,336 payments — averaging $1795.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$1.6M
  • Eli Lilly$1.1M
  • Takeda Pharmaceuticals U.S.A., Inc.$430K
  • Dermavant Sciences, Inc.$394K
  • Aclaris Therapeutics, Inc.$347K
  • Incyte Corporation$338K
  • plus $1.8M from 40 others
$516,595in research payments, 2019–2025

Across 16 payments — averaging $32,287 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Nielsen Biosciences, Inc.$481K
  • Eli Lilly$36K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,988,156 in reported general payments places this provider in the 95th percentile of 75 dermatology providers in Arkansas.

See all dermatology providers in Arkansas

Medicare billing

Part B allowed, 2024
$754,142
Medicare patients
1,209
Services billed
23,477

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in Fort Smith

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →